1. Xinxin Zhang, Feifei Li, Shiyan Guo, Xi Chen, Xiaoli Wang, Juan Li, Yong Gan. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells. Biomaterials. 35: 3650-3665,2014. 2. Xinxin Zhang, Xi Chen, Feifei Li, Shiyan Guo, Juan Li, Yong Gan. Smart lipid capped mesoporous silica nanoparticles with tumor extrcellular pH activated charge-conversion property for deep hepatocellular carcinoma penetration. J Control Release 213:e121, 2015 3. Xinxin Zhang, Shiyan Guo, Rong Fan, Yong Gan. Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells. Biomaterials. 33: 7103-7114,2012. 4. Na Wu, Xinxin Zhang*, Feifei Li, Tao Zhang, Yong Gan, Juan Li. Spray-dried powder enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure. Int J Nanomed. 10: 5383-5396, 2015. 5. Xinxin Zhang, Chi Zhang, Wei Xu, Biao Zhong, Feng Lin, et al. Biodegradable mesoporous magnesium calcium silicate-polybutylene succinate scaffolds for osseous tissue engineering. Int J Nanomed. 10: 6699-6708, 2015 6. Fei Yin, Shiyan Guo, Yong Gan, Xinxin Zhang*. Preparation of Redispersible Liposomal Dry Powder by Using an Ultrasonic Spray Freeze Drying Technique for Transdermal Delivery of Human Epithelial Growth Factor. Int J Nanomed. 9: 1665-1676, 2014. 7. Rui Yang, Xinxin Zhang*, Feifei Li, Lixia Ding, Bo Li, Yong Gan. Role of phospholipids and copolymers in enhancing stability and controlling degradation of intravenous lipid emulsions. Colloid Surface A:Physicochemical and Engineering Aspects. 436: 434-442,2013. 8. Yanping Wang, Yong Gan, Xinxin Zhang*. Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test. Acta Pharmacol Sin. 32: 1294-1302,2011. (IF:2.91) 9. Shiyan Guo, Xinxin Zhang*, Li Gan, Chunliu Zhu, Yong Gan. Effect of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) micelles on pharmacokinetics and intestinal toxicity of irinotecan hydrochloride: potential involvement of breast cancer resistance protein (ABCG2). J. Pharm. Pharmacol. 62: 973-984,2010. |